RxDoctor Payments Data

Alysia Zeigler, DO

Family Medicine · Struthers, OHNPI 1992069769

Payments from drug & device makers

$476in general payments, 2019–2025

Across 28 payments — averaging $17.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$107
  • Novo Nordisk$90
  • Biohaven Pharmaceuticals, Inc.$87
  • Biohaven Pharmaceutical Holding Company Ltd.$57
  • Merck$30
  • Novartis$25
  • plus $79 from 5 others

What the payments were for

  • Food & beverage$476100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$476 in reported general payments places this provider in the 50th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$29,159
Medicare patients
67
Services billed
472

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide76$113,629
OzempicSemaglutide72$103,125
EliquisApixaban110$99,039
JardianceEmpagliflozin57$67,229
MounjaroTirzepatide24$28,197
TradjentaLinagliptin33$22,106
Humalog Kwikpen U-100Insulin Lispro11$14,757
JanuviaSitagliptin Phosphate21$11,112
Lantus SolostarInsulin Glargine,hum.Rec.Anlog68$10,091
MyrbetriqMirabegron15$9,898
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$6,362
Albuterol Sulfate HfaAlbuterol Sulfate201$5,159
SynthroidLevothyroxine Sodium82$4,274
DuleraMometasone/Formoterol12$4,273
Epinephrine12$3,421

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$13$141,826100 claims
Novo NordiskOzempic$90$103,12572 claims
PfizerEliquis$18$99,039110 claims
MerckJanuvia, Dulera$30$15,38533 claims
AbbVieSynthroid$107$4,27482 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Struthers

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →